TNFAIP3 and rheumatoid arthritis: Collectively, these findings highlight the cell-specific regulatory functions of A20 in RA pathogenesis and support the development of A20-targeting strategies as a potential approach for cellular-level therapy in RA [13] (Table 2 and Figure 3).